BamSEC and AlphaSense Join Forces
Learn More

Pfizer Inc.

NYSE: PFE    
Share price (6/9/25): $23.97    
Market cap (6/9/25): $136 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 64 pages Pfizer Netherlands International Finance B.V., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee First Supplemental Indenture Dated as of May 19, 2025 to Indenture Dated as of May 19, 2025 2.875% Notes Due 2029 3.250% Notes Due 2032 3.875% Notes Due 2037 4.250% Notes Due 2045
12/34/56
EX-4.1
from 8-K 86 pages Pfizer Netherlands International Finance B.V., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee Indenture Dated as of May 19, 2025 Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.3
from POSASR 86 pages Pfizer Netherlands International Finance B.V., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee Indenture Dated as of [ ], 20[ ] Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.26
from 10-K 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.26
from 10-K 8 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 104 pages Pfizer Investment Enterprises Pte. Ltd., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee First Supplemental Indenture Dated as of May 19, 2023 to Indenture Dated as of May 19, 2023 4.650% Notes Due 2025 4.450% Notes Due 2026 4.450% Notes Due 2028 4.650% Notes Due 2030 4.750% Notes Due 2033 5.110% Notes Due 2043 5.300% Notes Due 2053 5.340% Notes Due 2063
12/34/56
EX-4.1
from 8-K 86 pages Pfizer Investment Enterprises Pte. Ltd., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee Indenture Dated as of May 19, 2023 Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.2
from POSASR 85 pages Pfizer Investment Enterprises Pte. Ltd., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee Indenture Dated as of [ ], 20[ ] Debt Securities Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.24
from 10-K 9 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.24
from 10-K 10 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 16 pages Pfizer Inc. and the Bank of New York Mellon, Trustee Fifth Supplemental Indenture Dated as of August 18, 2021 to Indenture Dated as of September 7, 2018 1.750% Notes Due 2031
12/34/56
EX-4.23
from 10-K 9 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 41 pages Pfizer Inc. and the Bank of New York Mellon, Trustee Fourth Supplemental Indenture Dated as of May 28, 2020 to Indenture Dated as of September 7, 2018 0.800% Notes Due 2025 1.700% Notes Due 2030 2.550% Notes Due 2040 2.700% Notes Due 2050
12/34/56
EX-4.2
from 8-K 15 pages Pfizer Inc. and the Bank of New York Mellon, Trustee Third Supplemental Indenture Dated as of March 27, 2020 to Indenture Dated as of September 7, 2018 2.625% Notes Due 2030
12/34/56
EX-4.21
from 10-K 14 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 48 pages Pfizer Inc. and the Bank of New York Mellon, Trustee Second Supplemental Indenture Dated as of March 11, 2019 to Indenture Dated as of September 7, 2018 2.800% Notes Due 2022 2.950% Notes Due 2024 3.450% Notes Due 2029 3.900% Notes Due 2039 4.000% Notes Due 2049
12/34/56
EX-4.2
from 8-K 60 pages Pfizer Inc. and the Bank of New York Mellon, Trustee First Supplemental Indenture Dated as of September 7, 2018 to Indenture Dated as of September 7, 2018 Floating Rate Notes Due 2023 3.000% Notes Due 2021 3.200% Notes Due 2023 3.600% Notes Due 2028 4.100% Notes Due 2038 4.200% Notes Due 2048
12/34/56
EX-4.1
from 8-K 81 pages Pfizer Inc. Indenture Dated as of September 7, 2018 Debt Securities the Bank of New York Mellon, Trustee Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.1
from S-3ASR 81 pages Pfizer Inc. Indenture Dated as of [ ], 20 Debt Securities the Bank of New York Mellon, Trustee Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture*
12/34/56
EX-4.2
from 8-K 42 pages Pfizer Inc. and the Bank of New York Mellon, as Trustee the Bank of New York Mellon, London Branch as Paying Agent Tenth Supplemental Indenture Dated as of December 19, 2017 to Indenture Dated as of January 30, 2001 £1,375,882,000 2.735 Per Cent. Notes Due 2043
12/34/56